Segment Information (Details) - Schedule of financial information related to our reportable segments and corporate - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Segment Reporting Information [Line Items] | ||||||
| Net revenue | $ 1,022,851 | $ 1,179,620 | $ 3,997,490 | $ 2,894,390 | $ 4,299,717 | $ 1,212,870 |
| Cost of revenue | 1,404,562 | 1,418,213 | 4,771,151 | 4,160,743 | 5,300,037 | 1,495,042 |
| Gross margin | (381,711) | (238,593) | (773,661) | (1,266,353) | (1,000,320) | (282,172) |
| Research and development | 234,965 | 322,946 | 686,131 | 708,396 | 983,528 | 257,431 |
| Marketing | 646,520 | 1,812,400 | 4,016,051 | 8,049,579 | 9,626,982 | 2,854,904 |
| Stock based compensation | 9,661,168 | 6,861,163 | ||||
| Impairment of goodwill | 1,035,795 | |||||
| General and administrative not including depreciation, amortization, or Impairment | 4,087,055 | 2,385,135 | 10,956,046 | 5,551,049 | 9,975,360 | 5,858,454 |
| Depreciation and amortization | 397,440 | 157,761 | ||||
| Impairment of intangibles | 688,127 | 11,450 | ||||
| Total operating expenses | 5,595,108 | 6,672,381 | 20,205,866 | 19,971,413 | 32,368,400 | 16,001,163 |
| Interest expense | (372,106) | (372,106) | ||||
| All other expenses | (3,638,327) | (7,557,342) | ||||
| Other expenses, net | (4,010,433) | (7,929,448) | ||||
| Loss before income tax provision and equity in net loss from unconsolidated investments | (9,526,345) | (9,720,121) | (25,112,331) | (24,925,834) | (37,379,153) | (24,212,783) |
| Creatd Labs [Member] | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net revenue | 291,414 | 565,852 | 1,138,904 | 1,388,411 | 1,926,374 | 375,043 |
| Cost of revenue | 564,349 | 849,079 | 1,917,039 | 2,482,848 | 3,186,240 | 652,259 |
| Gross margin | (272,935) | (283,227) | (778,135) | (1,094,437) | (1,259,866) | (277,216) |
| Research and development | 139,997 | 250,474 | 408,810 | 549,426 | 758,293 | 227,656 |
| Marketing | 370,584 | 1,540,540 | 2,301,994 | 6,842,142 | 8,182,935 | 2,426,668 |
| Stock based compensation | 1,727,021 | 1,226,495 | ||||
| Impairment of goodwill | ||||||
| General and administrative not including depreciation, amortization, or Impairment | 90,212 | 386,844 | 242,330 | 900,323 | 3,918,130 | 2,301,088 |
| Depreciation and amortization | ||||||
| Impairment of intangibles | ||||||
| Total operating expenses | 14,586,379 | 6,181,907 | ||||
| Interest expense | (12,706) | (15,828) | ||||
| All other expenses | ||||||
| Other expenses, net | (12,706) | (15,828) | ||||
| Loss before income tax provision and equity in net loss from unconsolidated investments | (1,001,024) | (2,802,443) | (4,524,814) | (10,286,156) | (15,858,951) | (6,474,951) |
| Creatd Ventures [Member] | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net revenue | 316,654 | 3,919 | 1,237,542 | 9,616 | 90,194 | |
| Cost of revenue | 502,396 | 174,438 | 1,706,586 | 497,194 | 148,989 | |
| Gross margin | (185,742) | (170,519) | (469,044) | (487,578) | (58,940) | |
| Research and development | 60 | 131 | 131 | |||
| Marketing | 234,760 | 1,458,280 | ||||
| Stock based compensation | 1,560,546 | |||||
| Impairment of goodwill | ||||||
| General and administrative not including depreciation, amortization, or Impairment | 476,386 | 302,764 | 1,279,676 | 76,381 | 1,665,783 | |
| Depreciation and amortization | 100,633 | |||||
| Impairment of intangibles | ||||||
| Total operating expenses | 3,327,093 | |||||
| Interest expense | ||||||
| All other expenses | ||||||
| Loss before income tax provision and equity in net loss from unconsolidated investments | (1,008,360) | (506,162) | (4,099,962) | (1,360,766) | (3,385,888) | |
| Creatd Partners [Member] | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net revenue | 414,783 | 609,849 | 1,621,044 | 1,496,363 | 2,283,149 | 837,827 |
| Cost of revenue | 337,817 | 394,696 | 1,147,526 | 1,180,701 | 1,964,808 | 842,783 |
| Gross margin | 76,966 | 215,153 | 473,518 | 315,662 | 318,341 | (4,956) |
| Research and development | 94,968 | 72,412 | 277,321 | 158,839 | 225,104 | 29,775 |
| Marketing | 41,176 | 181,240 | 255,777 | 804,958 | 962,698 | 285,490 |
| Stock based compensation | 1,884,986 | 1,338,678 | ||||
| Impairment of goodwill | 1,035,795 | |||||
| General and administrative not including depreciation, amortization, or Impairment | 384,365 | 293,296 | 1,032,487 | 682,602 | 1,600,212 | 939,792 |
| Depreciation and amortization | 252,730 | 132,768 | ||||
| Impairment of intangibles | 688,127 | |||||
| Total operating expenses | 6,649,652 | 2,726,504 | ||||
| Interest expense | ||||||
| All other expenses | ||||||
| Other expenses, net | ||||||
| Loss before income tax provision and equity in net loss from unconsolidated investments | (570,197) | (664,326) | (1,984,468) | (2,205,741) | (6,331,311) | (2,731,460) |
| Corporate [Member] | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Net revenue | ||||||
| Cost of revenue | ||||||
| Gross margin | ||||||
| Research and development | ||||||
| Marketing | 90,620 | 402,479 | 481,349 | 142,745 | ||
| Stock based compensation | 4,488,615 | 4,295,990 | ||||
| Impairment of goodwill | ||||||
| General and administrative not including depreciation, amortization, or Impairment | 3,136,092 | 1,672,176 | 8,401,553 | 3,891,743 | 2,791,236 | 2,592,581 |
| Depreciation and amortization | 44,076 | 24,993 | ||||
| Impairment of intangibles | 11,450 | |||||
| Total operating expenses | 11,803,003 | 7,067,759 | ||||
| Interest expense | (359,400) | (356,278) | ||||
| All other expenses | (3,638,327) | (7,557,342) | ||||
| Other expenses, net | (3,997,727) | (7,913,620) | ||||
| Loss before income tax provision and equity in net loss from unconsolidated investments | $ (6,946,764) | $ (5,747,190) | $ (14,503,087) | $ (11,073,171) | $ (11,803,003) | $ (14,981,379) |